For citations:
Lisitsyna T.A., Abramkin A.A., Veltishchev D.Yu., Borisova A.B., Nasonov E.L. Efficacy of olokizumab in treating comorbid depression in patients with rheumatoid arthritis: results of a single-center randomized controlled trial. Rheumatology Science and Practice. 2025;63(5):452-462. (In Russ.) https://doi.org/10.47360/1995-4484-2025-452-462































